151 related articles for article (PubMed ID: 1394667)
1. Imidazo[1,2-alpha]pyridines. III. Synthesis and bradycardic activity of new 5-imidazo[1,2-alpha]pyridin-6-ylpyridine derivatives.
Yamanaka M; Suda S; Kabasawa Y; Kawamura T; Ogawa T; Sawada K; Ohhara H
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1486-93. PubMed ID: 1394667
[TBL] [Abstract][Full Text] [Related]
2. Imidazo[1,2-alpha]pyridines. II. Ozonolysis of imidazo[1,2-alpha]pyridines and synthesis of cardiotonic agents.
Yamanaka M; Suda S; Yoneda N; Ohhara H
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):666-74. PubMed ID: 1611679
[No Abstract] [Full Text] [Related]
3. Cardiotonic agents. 1. Novel 8-aryl-substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents.
Davey D; Erhardt PW; Lumma WC; Wiggins J; Sullivan M; Pang D; Cantor E
J Med Chem; 1987 Aug; 30(8):1337-42. PubMed ID: 3039131
[TBL] [Abstract][Full Text] [Related]
4. Inotropic activities of imidazopyridines.
Barraclough P; Black JW; Cambridge D; Gerskowitch VP; Hull RA; Lyer R; King WR; Kneen CO; Nobbs MS; Shah GP
Arch Pharm (Weinheim); 1990 Aug; 323(8):501-5. PubMed ID: 2278516
[TBL] [Abstract][Full Text] [Related]
5. Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives.
Yamanaka M; Miyake K; Suda S; Ohhara H; Ogawa T
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1556-67. PubMed ID: 1934178
[TBL] [Abstract][Full Text] [Related]
6. [Imidazole derivatives. V. Synthesis and pharmacological activity of alkyl derivatives of imidazo-(1,2-a)-pyridine].
Almirante L; Mugnaini A; De Toma N; Murmann W
Boll Chim Farm; 1971 Jun; 110(6):317-21. PubMed ID: 5110579
[No Abstract] [Full Text] [Related]
7. [Imidazo(1,2a)pyridines with antiulcer activity].
Del Corona L; Pellegatta C; Signorelli G; Buran V; Massaroli G; Turba C; Faini D; Pagella PG
Farmaco Sci; 1981 Dec; 36(12):994-1003. PubMed ID: 7319025
[No Abstract] [Full Text] [Related]
8. Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine.
Robertson DW; Beedle EE; Krushinski JH; Pollock GD; Wilson H; Wyss VL; Hayes JS
J Med Chem; 1985 Jun; 28(6):717-27. PubMed ID: 4009593
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent.
Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T
Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028
[TBL] [Abstract][Full Text] [Related]
10. Imidazole derivatives. IV. Synthesis and pharmacologic activity of oxygenated derivatives of imidazo(1,2-a)pyridine.
Almirante L; Mugnaini A; De Toma N; Gamba A; Murmann W
J Med Chem; 1970 Nov; 13(6):1048-51. PubMed ID: 4991390
[No Abstract] [Full Text] [Related]
11. Imidazopyridines: roles of pyridine nitrogen position and methylsulfinyl oxygen for in vitro positive inotropic mechanism and chronotropic activity.
Honerjäger P; Klockow M; Schönsteiner G; Jonas R
J Cardiovasc Pharmacol; 1989 May; 13(5):673-81. PubMed ID: 2472514
[TBL] [Abstract][Full Text] [Related]
12. Antiulcer agents. 3. Structure-activity-toxicity relationships of substituted imidazo[1,2-a]pyridines and a related imidazo[1,2-a]pyrazine.
Kaminski JJ; Perkins DG; Frantz JD; Solomon DM; Elliott AJ; Chiu PJ; Long JF
J Med Chem; 1987 Nov; 30(11):2047-51. PubMed ID: 3669012
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.
Krause M; Foks H; Gobis K
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273868
[TBL] [Abstract][Full Text] [Related]
14. Chemistry, pharmacology, and structure-activity relationships with a new type of imidazolines exerting a specific bradycardic action at a cardiac site.
Stähle H; Daniel H; Kobinger W; Lillie C; Pichler L
J Med Chem; 1980 Nov; 23(11):1217-22. PubMed ID: 7452671
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new imidazo[1,2-a]pyridine derivatives designed as mefloquine analogues.
Lima PC; Avery MA; Tekwani BL; de Alves HM; Barreiro EJ; Fraga CA
Farmaco; 2002 Oct; 57(10):825-32. PubMed ID: 12420878
[TBL] [Abstract][Full Text] [Related]
16. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of respiratory stimulant amides of imidazo(1,2-a)pyridine-2,3-dicarboxylic acids.
Casagrande C; Ferrini R; Miragoli G; Ferrari G
Farmaco Sci; 1972 Sep; 27(9):715-30. PubMed ID: 4666083
[No Abstract] [Full Text] [Related]
18. Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analogues.
Kaminski JJ; Hilbert JM; Pramanik BN; Solomon DM; Conn DJ; Rizvi RK; Elliott AJ; Guzik H; Lovey RG; Domalski MS
J Med Chem; 1987 Nov; 30(11):2031-46. PubMed ID: 3669011
[TBL] [Abstract][Full Text] [Related]
19. Directed solid-phase synthesis of trisubstituted imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
Lemrová B; Smyslová P; Popa I; Oždian T; Zajdel P; Soural M
ACS Comb Sci; 2014 Oct; 16(10):558-65. PubMed ID: 25046560
[TBL] [Abstract][Full Text] [Related]
20. Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridines.
Kaminski JJ; Bristol JA; Puchalski C; Lovey RG; Elliott AJ; Guzik H; Solomon DM; Conn DJ; Domalski MS; Wong SC
J Med Chem; 1985 Jul; 28(7):876-92. PubMed ID: 4009611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
